BBC Health 25 Oct 2026
Wellbeing support demand for cancer patients grows
Macmillan Cancer Support Jersey publishes its annual report looking back at 2025.
25 Oct 2026
Read →
These trials are currently recruiting participants in the UK. Always speak to your GP or specialist before contacting a trial team.
The trial will be a phase III, randomised-controlled, multi-centre, international, open-label trial consisting of ruxolitinib versus best available therapy, where best available…
This is a multi-center, open label, phase II study of tebentafusp in patients with unresectable or metastatic clear cell sarcoma (CCS).
The purpose of this study is to understand the safety, tolerability, efficacy, pharmacokinetic (PK), pharmacodynamic (PD), and preliminary efficacy of orally administered…
An open-label, multi-site, multi-cohort phase 1/2 trial to be conducted in 2 parts (dose escalation and dose expansion/optimisation)
The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus…
This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this…
Your patient insight is valuable. Take a short survey and help researchers improve treatments for Cancer.
Living with Cancer? Your experience can help others. Share what you've learned.
Thousands of UK patients are managing Cancer. Connect, share experiences, and support each other.
The latest pipeline drugs, clinical breakthroughs, and regulatory approvals from the FDA, EMA and NICE for Cancer patients.
TA1202
TA1197
📋 Information sourced from clinical trial registries, FDA, EMA and published research
View all research →No podcasts available yet for Cancer
Sign up for updates below to be notified when we release a free patient podcast for this area.